Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study.
Gastrointestinal stromal tumor (GIST) has been considered radiation-resistant, and radiotherapy is recommended only for palliation of bone metastases in current treatment guidelines. No registered prospective trial has evaluated GIST responsiveness to radiotherapy.
